Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Holodniy

Showing results (1-10 of 169) with videos related to

Pageof 17
Sort By:
The Journal of Infectious Diseases|August 22, 2006
HIV-1 load quantitation: a 17-year perspectiveMark Holodniy
Expert Review of Vaccines|September 23, 2006
Prevention of shingles by varicella zoster virus vaccinationMark Holodniy
Drugs|December 8, 2007
Darunavir in the treatment of HIV-1 infection: a viewpoint by Mark HolodniyMark Holodniy
Expert Opinion on Drug Safety|April 10, 2009
Oseltamivir for treatment and prophylaxis of influenza infectionPatricia Schirmer, Mark Holodniy
Current Cardiology Reviews|November 26, 2009
The Relationship Between HIV Infection and Cardiovascular DiseaseBirgitt Dau, Mark Holodniy
Clinics in Laboratory Medicine|September 25, 2002
HIV-1 RNA and viral loadKaren Relucio, Mark Holodniy
Infection and Drug Resistance|November 27, 2013
Influenza treatment and prophylaxis with neuraminidase inhibitors: a reviewAmanda Kamali, Mark Holodniy
Reviews on Recent Clinical Trials|May 21, 2010
Recent advances in hepatitis C virus treatment: review of HCV protease inhibitor clinical trialsAarthi Chary, Mark Holodniy
Immunotherapy|September 15, 2011
Interferon combination therapy for HIV/hepatitis C virus coinfectionAarthi Chary, Mark Holodniy
Drugs|February 6, 2009
Novel targets for antiretroviral therapy: clinical progress to dateBirgitt Dau, Mark Holodniy
Pageof 17

Showing results (1-10 of 169) with videos related to

Sort By:
Pageof 17
The Journal of Infectious Diseases|August 22, 2006
HIV-1 load quantitation: a 17-year perspectiveMark Holodniy
Expert Review of Vaccines|September 23, 2006
Prevention of shingles by varicella zoster virus vaccinationMark Holodniy
Drugs|December 8, 2007
Darunavir in the treatment of HIV-1 infection: a viewpoint by Mark HolodniyMark Holodniy
Expert Opinion on Drug Safety|April 10, 2009
Oseltamivir for treatment and prophylaxis of influenza infectionPatricia Schirmer, Mark Holodniy
Current Cardiology Reviews|November 26, 2009
The Relationship Between HIV Infection and Cardiovascular DiseaseBirgitt Dau, Mark Holodniy
Clinics in Laboratory Medicine|September 25, 2002
HIV-1 RNA and viral loadKaren Relucio, Mark Holodniy
Infection and Drug Resistance|November 27, 2013
Influenza treatment and prophylaxis with neuraminidase inhibitors: a reviewAmanda Kamali, Mark Holodniy
Reviews on Recent Clinical Trials|May 21, 2010
Recent advances in hepatitis C virus treatment: review of HCV protease inhibitor clinical trialsAarthi Chary, Mark Holodniy
Immunotherapy|September 15, 2011
Interferon combination therapy for HIV/hepatitis C virus coinfectionAarthi Chary, Mark Holodniy
Drugs|February 6, 2009
Novel targets for antiretroviral therapy: clinical progress to dateBirgitt Dau, Mark Holodniy
Pageof 17